K003291

Substantially Equivalent

BAYER DIAGNOSTICS ACS:180 AND ADVIA CENTAUR ANTI-TPO ASSAY

Applicant: Bayer Diagnostics Corp.
Product code: JZO
Advisory panel: Immunology
Date received: 2000-10-20
Decision date: 2000-12-05
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Medfield, MA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.